Medicamen Biotech Limited (MEDICAMEQ) — Capital Reinvestment Ratio
Medicamen Biotech Limited (MEDICAMEQ) has a Capital Reinvestment Ratio of 2.09x as of March 2022, meaning it reinvests 2% of its operating cash flow (Rs41.09 Million) in capital expenditures (Rs86.08 Million). See net asset quality index of Medicamen Biotech Limited to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medicamen Biotech Limited Capital Reinvestment Ratio (2006–2022)
This chart tracks Medicamen Biotech Limited's Capital Reinvestment Ratio across 13 annual periods. Check Medicamen Biotech Limited total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Medicamen Biotech Limited (2006–2022)
Year-by-year Capital Reinvestment Ratio for Medicamen Biotech Limited from 2006 to 2022. For live market cap and broader valuation context, see MEDICAMEQ company net worth.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.09x | Rs41.09 Million | Rs86.08 Million | ▲ +48.9% |
| 2021 | 1.41x | Rs127.72 Million | Rs179.66 Million | ▼ -52.1% |
| 2020 | 2.94x | Rs128.02 Million | Rs376.11 Million | ▼ -19.4% |
| 2019 | 3.65x | Rs43.01 Million | Rs156.81 Million | ▲ +464.6% |
| 2017 | 0.65x | Rs35.92 Million | Rs23.20 Million | ▲ +494.8% |
| 2016 | 0.11x | Rs62.06 Million | Rs6.74 Million | ▼ -43.1% |
| 2014 | 0.19x | Rs51.39 Million | Rs9.80 Million | ▼ -44.4% |
| 2011 | 0.34x | Rs113.52 Million | Rs38.93 Million | ▼ -89.3% |
| 2010 | 3.20x | Rs11.00 Million | Rs35.20 Million | ▲ +1210.1% |
| 2009 | 0.24x | Rs83.07 Million | Rs20.29 Million | ▼ -82.7% |
| 2008 | 1.41x | Rs22.70 Million | Rs31.97 Million | ▼ -92.8% |
| 2007 | 19.44x | Rs2.59 Million | Rs50.30 Million | ▲ +2501.1% |
| 2006 | 0.75x | Rs26.02 Million | Rs19.45 Million | — |